By continuing on our website, you agree to our use of the cookie for statistical and personalization purpose.
Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
blog / Jan 24, 2022
Health law expert Timothy Jost delves into the Supreme Court’s recent rulings on the Biden administration’s COVID-19 vaccination mandates.
blog / Jan 07, 2022
blog / Dec 22, 2021
Search All To the Point Posts
Blog / Sep 30, 2009
Blog / Aug 18, 2009
Blog / Jul 08, 2009
Blog / Jun 22, 2009
Sign up to receive e-alerts and newsletters on the health policy topic you care about most.